CAA 2022 Prescription Drug Data Collection (RxDC)

On May 24, 2023, PharmAvail successfully submitted 2022 Reference Year data in accordance with the Consolidated Appropriations Act, 2021 (CAA) ahead of the June 1 deadline.

Thumbnail of CAA 2022 Prescription Drug Data Collection (RxDC)

CAA 2022 RxDC Submission

On May 24, 2023, PharmAvail successfully submitted 2022 Reference Year data in accordance with the Consolidated Appropriations Act, 2021 (CAA).  Section 204 of the CAA requires insurance companies and health plans to submit pharmacy benefit and drug cost data annually.

For our client’s convenience, our team submitted all data free of charge ahead of the June 1 deadline.

The following information was submitted for PharmAvail clients required to submit:

P2: Group Health Plan List

D3: Top 50 Most Frequent Brand Drugs

D4: Top 50 Most Costly Drugs

D5: Top 50 Drugs by Spending Increase

D6: Total Drug Spending (Under Pharmacy Benefit)

D7: Rx Rebates by Therapeutic Class

D8: Rx Rebates for the Top 25 Drugs

We are pleased to provide this service at no charge to our clients. At PharmAvail, we work closely with our clients to ensure their unique needs are met.  Known for our high-touch service, actionable analytics, and forward-thinking management strategies, we take a collaborative approach to controlling costs without compromising care.

If you have any questions, please contact us directly at customersupport@rxipm.com.